Therefore, pharmacological and/or genetic blockage of key nodes of the HSP90/AXL/eIF4E/UPR signaling cascade selectively induces apoptotic cell death of drug-resistant cancer cells, limits tumor heterogeneity in vitro, and precludes the emergence of adaptive phenotypes in vivo. The gene discussed is HSP90AB1; the disease is neoplasm.